Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Aspirin use and melanoma risk: a review of the literature.

Famenini S, Young LC.

J Am Acad Dermatol. 2014 Jan;70(1):187-91. doi: 10.1016/j.jaad.2013.09.045. Review.

PMID:
24355265
2.

Aspirin and other NSAIDs as chemoprevention agents in melanoma.

Goodman JR, Grossman D.

Cancer Prev Res (Phila). 2014 Jun;7(6):557-64. doi: 10.1158/1940-6207.CAPR-14-0018. Epub 2014 Apr 2. Review.

3.

Role of aspirin and non-aspirin NSAIDs in preventing melanoma.

Ally MS, Swetter SM, Tang JY.

Future Oncol. 2013 Nov;9(11):1671-4. doi: 10.2217/fon.13.112. Epub 2013 Jun 3. No abstract available.

PMID:
23731359
4.

A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.

Asgari MM, Maruti SS, White E.

J Natl Cancer Inst. 2008 Jul 2;100(13):967-71. doi: 10.1093/jnci/djn154. Epub 2008 Jun 24.

5.

Aspirin as a chemoprevention agent for colorectal cancer.

Lee CS, McNamara D, O'Morain CA.

Curr Drug Metab. 2012 Nov;13(9):1313-22. Review.

PMID:
22493984
6.

Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.

Clouser MC, Roe DJ, Foote JA, Harris RB.

Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):276-83. doi: 10.1002/pds.1718.

PMID:
19226541
7.

Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.

Muranushi C, Olsen CM, Pandeya N, Green AC.

J Invest Dermatol. 2015 Apr;135(4):975-983. doi: 10.1038/jid.2014.531. Epub 2014 Dec 18. Review.

8.

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study.

Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB, Sørensen HT.

Cancer. 2012 Oct 1;118(19):4768-76. doi: 10.1002/cncr.27406. Epub 2012 May 29.

9.

Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.

Baandrup L, Faber MT, Christensen J, Jensen A, Andersen KK, Friis S, Kjaer SK.

Acta Obstet Gynecol Scand. 2013 Mar;92(3):245-55. doi: 10.1111/aogs.12069. Epub 2013 Jan 22. Review.

PMID:
23240575
10.

CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.

Bigler J, Whitton J, Lampe JW, Fosdick L, Bostick RM, Potter JD.

Cancer Res. 2001 May 1;61(9):3566-9.

11.

Inverse association of non-steroidal anti-inflammatory drugs and malignant melanoma among women.

Harris RE, Beebe-Donk J, Namboodiri KK.

Oncol Rep. 2001 May-Jun;8(3):655-7.

PMID:
11295097
12.

Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF Jr, Blot WJ.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):97-102.

13.

Do nonsteroidal anti-inflammatory drugs prevent melanoma?

Bard S, Kirsner RS.

J Invest Dermatol. 2011 Jul;131(7):1394. doi: 10.1038/jid.2011.154. No abstract available.

14.

Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents.

Greenberg ER, Baron JA.

IARC Sci Publ. 1996;(139):91-8. Review.

PMID:
8923021
15.

The search for a chemoprevention agent effective against melanoma: considerations and challenges.

Ming ME.

J Invest Dermatol. 2011 Jul;131(7):1401-3. doi: 10.1038/jid.2011.83.

16.

Nonsteroidal anti-inflammatory drugs in skin cancer: revisited.

al-Saleem T.

J Natl Cancer Inst. 1993 Apr 7;85(7):581-2. No abstract available.

PMID:
8455205
17.

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.

DuBois RN, Giardiello FM, Smalley WE.

Gastroenterol Clin North Am. 1996 Dec;25(4):773-91. Review.

PMID:
8960892
18.

Aspirin may lower melanoma risk.

[No authors listed]

Harv Womens Health Watch. 2013 Jun;20(10):8. No abstract available.

PMID:
23977710
19.

Prospective study of regular aspirin use and the risk of breast cancer.

Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA.

J Natl Cancer Inst. 1996 Jul 17;88(14):988-93.

PMID:
8667430
20.

Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study.

Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB, Stern RS.

J Invest Dermatol. 2011 Jul;131(7):1460-8. doi: 10.1038/jid.2011.58. Epub 2011 Mar 10.

Supplemental Content

Support Center